It’s a federal appeals court decision that is either a victory for free speech or a significant threat to public health. While doctors can prescribe an approved drug for any purpose, FDA regulations have long held that companies may only market a drug for its approved use. This decision could open the door to television advertising for off-label uses of drugs. Caveat emptor!
Lisa Aliferis is the founding editor of KQED's State of Health blog. Since 2011, she's been writing and editing stories for the site. Before taking up blogging, she toiled for many years (more than we can count) producing health stories for television, including Dateline NBC and San Francisco's CBS affiliate, KPIX-TV. She also wrote up a handy guide to the Affordable Care Act, especially for Californians. Her work has been honored for many awards. Most recently she was a finalist for "Best Topical Reporting" from the Online News Association. You can follow her on Twitter: @laliferis